|
1
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Du X, Cheng Z, Wang YH, Guo ZH, Zhang SQ,
Hu JK and Zhou ZG: Role of Notch signaling pathway in gastric
cancer: A meta-analysis of the literature. World J Gastroenterol.
20:9191–9199. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dey BK, Mueller AC and Dutta A: Long
non-coding RNAs as emerging regulators of differentiation,
development, and disease. Transcription. 5(e944014)2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pan LJ, Zhong TF, Tang RX, Li P, Dang YW,
Huang SN and Chen G: Upregulation and clinicopathological
significance of long non-coding NEAT1 RNA in NSCLC tissues. Asian
Pac J Cancer Prev. 16:2851–2855. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li Y, Chen D, Gao X, Li X and Shi G:
LncRNA NEAT1 regulates cell viability and invasion in esophageal
squamous cell carcinoma through the miR-129/CTBP2 axis. Dis
Markers. 2017(5314649)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wu Y, Yang L, Zhao J, Li C, Nie J, Liu F,
Zhuo C, Zheng Y, Li B, Wang Z and Xu Y: Nuclear-enriched abundant
transcript 1 as a diagnostic and prognostic biomarker in colorectal
cancer. Mol Cancer. 14(191)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mang Y, Li L, Ran J, Zhang S, Liu J, Li L,
Chen Y, Liu J, Gao Y and Ren G: Long noncoding RNA NEAT1 promotes
cell proliferation and invasion by regulating hnRNP A2 expression
in hepatocellular carcinoma cells. Onco Targets Ther. 10:1003–1016.
2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhen L, Yun-Hui L, Hong-Yu D, Jun M and
Yi-Long Y: Long noncoding RNA NEAT1 promotes glioma pathogenesis by
regulating miR-449b-5p/c-Met axis. Tumour Biol. 37:673–683.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gong W, Zheng J, Liu X, Ma J, Liu Y and
Xue Y: Knockdown of NEAT1 restrained the malignant progression of
glioma stem cells by activating microRNA let-7e. Oncotarget.
7:62208–62223. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen X, Kong J, Ma Z, Gao S and Feng X: Up
regulation of the long non-coding RNA NEAT1 promotes esophageal
squamous cell carcinoma cell progression and correlates with poor
prognosis. Am J Cancer Res. 5:2808–2815. 2015.PubMed/NCBI
|
|
13
|
Tafrihi M and Hasheminasab E: miRNAs:
Biology, biogenesis, their web-based tools, and databases.
Microrna. 8:4–27. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu Y, Xing R, Zhang X, Dong W, Zhang J,
Yan Z, Li W, Cui J and Lu Y: miR-375 targets the p53 gene to
regulate cellular response to ionizing radiation and etoposide in
gastric cancer cells. DNA Repair (Amst). 12:741–750.
2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jiang L, Lin T, Xu C, Hu S, Pan Y and Jin
R: miR-124 interacts with the Notch1 signalling pathway and has
therapeutic potential against gastric cancer. J Cell Mol Med.
20:313–322. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie
Y, Li S, Tang G, Tang H and He X: MicroRNA-124 inhibits
proliferation and induces apoptosis by directly repressing EZH2 in
gastric cancer. Mol Cell Biochem. 392:153–159. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ma Z, Liu T, Huang W, Liu H, Zhang HM, Li
Q, Chen Z and Guo AY: MicroRNA regulatory pathway analysis
identifies miR-142-5p as a negative regulator of TGF-β pathway via
targeting SMAD3. Oncotarget. 7:71504–71513. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Grochowski CM, Loomes KM and Spinner NB:
Jagged1 (JAG1): Structure, expression, and disease associations.
Gene. 576:381–384. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jia CM, Tian YY, Quan LN, Jiang L and Liu
AC: miR-26b-5p suppresses proliferation and promotes apoptosis in
multiple myeloma cells by targeting JAG1. Pathol Res Pract.
214:1388–1394. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xiao HJ, Ji Q, Yang L, Li RT, Zhang C and
Hou JM: In vivo and in vitro effects of microRNA-124 on human
gastric cancer by targeting JAG1 through the Notch signaling
pathway. J Cell Biochem. 119:2520–2534. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ministry of Science and Technology of the
People's Republic of China. Guide for the care and use of
laboratory animals. Ministry of Science and Technology of the
People's Republic of China, Beijing, People's Republic of China (In
Chinese).
|
|
24
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chen J, Li Y, Zheng Q, Bao C, He J, Chen
B, Lyu D, Zheng B, Xu Y, Long Z, et al: Circular RNA profile
identifies circPVT1 as a proliferative factor and prognostic marker
in gastric cancer. Cancer Lett. 388:208–219. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wei GH and Wang X: lncRNA MEG3 inhibit
proliferation and metastasis of gastric cancer via p53 signaling
pathway. Eur Rev Med Pharmacol Sci. 21:3850–3856. 2017.PubMed/NCBI
|
|
27
|
Fu JW, Kong Y and Sun X: Long noncoding
RNA NEAT1 is an unfavorable prognostic factor and regulates
migration and invasion in gastric cancer. J Cancer Res Clin Oncol.
142:1571–1579. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang J, Zhao B, Chen X, Wang Z, Xu H and
Huang B: Silence of long noncoding RNA NEAT1 inhibits malignant
biological behaviors and chemotherapy resistance in gastric cancer.
Pathol Oncol Res. 24:109–113. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liu HS and Xiao HS: MicroRNAs as potential
biomarkers for gastric cancer. World J Gastroenterol.
20:12007–12017. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui
J, Liu Y, Gao Z, Li J, Shen L and Lu Y: Combination of hsa-miR-375
and hsa-miR-142-5p as a predictor for recurrence risk in gastric
cancer patients following surgical resection. Ann Oncol.
22:2257–2266. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shen WW, Zeng Z, Zhu WX and Fu GH:
miR-142-3p functions as a tumor suppressor by targeting CD133,
ABCG2, and Lgr5 in colon cancer cells. J Mol Med (Berl).
91:989–1000. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li D, Masiero M, Banham AH and Harris AL:
The notch ligand JAGGED1 as a target for anti-tumor therapy. Front
Oncol. 4(254)2014.PubMed/NCBI View Article : Google Scholar
|
